Novo Nordisk announced that NovoPen Echo is now available. NovoPen Echo is the first insulin pen device available with half-unit dosing and a memory function that records the dose and elapsed time ...

The agreement covers integrating DBL-4pen™, Diabeloop's self-learning algorithm for MDI therapy, with Novo Nordisk's connected and reusable insulin pens, NovoPen® 6 and NovoPen Echo® Plus.

When the original NovoPen came out a couple of decades ago it really broke the mould. The new NovoPen 4 from Novo Nordisk is even better. Generally acknowledged as a bit of a design classic, the ‘pen’ ...

This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected ...

Twenty years on, insulin pen devices have become an established and popular method of diabetes management with the NovoPen ® family of devices continuing to provide a valuable aid for diabetic ...

Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to ...

Diabeloop SA reported a partnership with Novo Nordisk A/S. The med-tech is planning to integrate DBL-4pen, its self-learning algorithm for multiple daily injection therapy, into Novo Nordisk's ...

* THE LAUNCH OF NOVO NORDISK'S FIRST CONNECTED INSULIN PENS, NOVOPEN® 6 AND NOVOPEN ECHO® PLUS, WILL COMMENCE IN THE FIRST QUARTER OF 2019 AND ROLL OUT TO OVER 50 COUNTRIES IN THE COMING YEARS ...

Patients with diabetes using a NovoPen Echo from one of the affected batches listed above should call Novo Nordisk at 1-855-419-8827 between 8 a.m. and 6 p.m. Eastern time to get a replacement ...

A total of 1194 patients using the NovoPen 6 and CGM were included in the analysis, which examined 110,264 total days of data from the cohort. The mean (standard deviation [SD]) number of bolus ...

Two pens are locked in a legal battle. The combatants are Novo Nordisk's NovoPen 4 (pictured), and Sanofi-Aventis's recently approved SoloStar. The pens are used as an alternative to conventional ...